The Inflammatory Burden in Hemodialysis vs. Peritoneal Dialysis Patients: the Role of Alpha-defensin

Hillel Yaffe Medical Center80 enrolled

Overview

The aim of this study is to determine the levels of alpha-defensin throughout the hemodialysis course compared to the levels at the end of a course of peritoneal dialysis, as a reflection of the inflammatory burden.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Kidney Failure Inflammation

Interventions

Blood TestDIAGNOSTIC_TEST

Blood test taken and sent for laboratory analysis

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Kidney failure patients undergoing hemodialysis or peritoneal dialysis Exclusion Criteria: * Active inflammatory or infectious disease

Locations (1)

Hillel Yaffe Medical Center

Hadera, Israel

Outcomes

Primary Outcomes

Alpha-Defensin Levels

Alpha-defensin levels will be compared between the two arms

Time frame: One year

Central Contacts

Rami Abu Fanne, MD, PhD

CONTACT

972-50-3573694 ramia@hadassah.org.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.